ABSTRACT Background: Oxidative and inflammatory stresses are involved in the pathogenesis of atherosclerosis. The consumption of fruit and vegetables is associated with improved health and reduced cardiovascular risk. Red oranges have a high content of antioxidant and antiinflammatory substances, but there is a paucity of data concerning their effects on cardiovascular biomarkers in subjects with increased cardiovascular risk. Objective: We investigated the effect of red orange juice intake on endothelial function, oxidative stress, and markers of inflammation in subjects with increased cardiovascular risk. Design: Nineteen nondiabetic subjects with increased cardiovascular risk (aged 27-56 y) were included in a randomized, placebocontrolled, single-blind crossover study and compared with 12 healthy, nonobese control subjects. In 2 periods of 7 d each with a 3-d interval, each participant alternatively received 500 mL red orange juice/d and 500 mL placebo/d in a random sequence. All measurements were performed in the morning after overnight fasting. Results: Endothelial function, which was measured as flow-mediated dilation, significantly improved and was normalized (5.7% compared with 7.9%; P , 0.005) after 1 wk of red orange juice consumption. Similarly, concentrations of high-sensitivity C-reactive protein, IL-6, and TNF-a significantly decreased (P , 0.001). Red orange juice had no significant effect on nitric oxide plasma concentrations. Conclusion: A 7-d consumption of red orange juice ameliorates endothelial function and reduces inflammation in nondiabetic subjects with increased cardiovascular risk. This trial was registered at biomedcentral.com as ISRCTN39987296.
INTRODUCTION
Cardiovascular disease (CVD) 4 is the leading cause of morbidity and mortality in the Western world. The increased production of reactive oxygen species (ROS) and oxidative and inflammatory stresses are associated with increased cardiovascular risk (CVR) in patients with diabetes, hypertension, central obesity, and dislipidemia and, in general, in patients affected by the metabolic syndrome (MetS).
Impaired endothelial function is involved in the pathogenesis of atherosclerosis and CVDs. Impaired endothelial function is characterized by a reduction in the bioavailability of nitric oxide (NO), which is a potent vasodilator and inhibitor of platelet adhesion and aggregation, with antiinflammatory and anti-proliferative properties (1, 2) . Endothelial function is measured in vivo by flow-mediated dilation (FMD) in the brachial artery. The FMD has proven to be a strong predictor of cardiovascular events (3) (4) (5) (6) . The FMD is influenced by many factors, including insulin resistance, diabetes, drugs, and diet (7) (8) (9) (10) (11) . Both inflammation and endothelial function play key roles in the activation and progression of atherosclerosis (12) . Epidemiologic studies suggested that high intakes of fruit and vegetables, which are 2 important components of the Mediterranean diet, are associated with a reduced risk of coronary artery disease. This beneficial effect has been related to the antioxidant content of these foods. Orange juice antagonizes oxidative and inflammatory stress (13) . This effect is at least partially attributed to the presence of hesperidin and naringenin, which are 2 flavonoids that suppress ROS generation in vitro (14) . Red orange Italian cultivars (Tarocco, Moro, and Sanguinello) may have an enhanced antioxidant activity and cardiovascular protective effects because of the presence of anthocyanins, which are the flavonoids responsible for the typical red color (15) . We hypothesized that the regular intake of red orange juice (ROJ) may have short-term favorable effects on the endothelial function of subjects with increased CVR, probably as a consequence of the reduction of the oxidative stress or antiinflammatory properties.
To test this hypothesis, we evaluated whether daily ROJ consumption for a week affected FMD, oxidative stress, and markers of inflammation in nondiabetic subjects with 2 of the diagnostic criteria of MetS.
SUBJECTS AND METHODS

Subjects
Twenty-one subjects with increased CVR (CVR group) voluntarily participated in the study after responding to an announcement posted in the medical center. There was no incentive provided to participants. The study protocol was approved by the Ethics Committee of the University Hospital Policlinico "P. Giaccone" (Palermo, Italy), and an approved informed consent form was signed by each subject. This study was registered as an International Standardized Randomized Controlled Trial (www. biomedcentral.com; ISRCTN39987296).
The study period was from March 2010 to May 2010. Subject inclusion criteria were age 18-70 y, BMI [body weight divided by height squared (in kg/m 2 )] .28, and the presence of 2 of the following diagnostic criteria of the MetS (16): waist circumference .80 cm for women and .94 cm for men, serum triglyceride concentration .150 mg/dL, serum concentration of HDL-cholesterol ,50 mg/dL for women and ,40 mg/dL for men, systolic blood pressure .130 mm Hg or diastolic blood pressure .85 mm Hg, and fasting plasma glucose concentration .100 mg/dL. Exclusion criteria included patients with type 1 or 2 diabetes, gastrointestinal or connective diseases, chronic pancreatitis, liver cirrhosis, kidney stones, or renal failure; use of acetyl-salicylic acid or other antiplatelet drugs, statins of fibrates, oral hypoglycemic drugs, nitrates, nonsteroidal antiinflammatory drugs, corticosteroids, or drugs interfering with coagulation; supplementation with vitamins or antioxidants; pregnancy or lactation in the past 6 mo; and regular sport activity. One subject was excluded because of the appearance of a tooth abscess that required antiinflammatory and antibiotic drug treatment; another subject was excluded because he reported not having taken the quantity of orange juice indicated. Therefore, 19 subjects were included in the CVR group. Twelve healthy, nonobese (BMI of 18-29.9) subjects were included as control subjects. Characteristics of the 2 groups are listed in Table 1 .
Study design
The study followed a randomized, 2 · 2 crossover, placebocontrolled, single-blind design. Each participant was studied for 2 periods of 7 6 1 d (periods 1 and 2), separated by a 3-d interval. Subjects were randomly assigned to consume 500 mL ROJ/d (250 mL ROJ twice daily) or 500 mL placebo/d (250 mL placebo twice daily), which was made up of water, orange aroma, colorants (azorubin and tartrazine), 11g sucrose, and 1g citric acid. Therefore, subjects who received ROJ for the first week were given the placebo for the second week and vice versa.
Anthropometric measurements, routine blood tests, an oral glucose (75 g) tolerance test, an electrocardiogram, and a carotid echo-Doppler were obtained in all subjects before they participated in the study. Anthropometric measurements were also obtained also at the end of the study. Subjects had 3 repeated visits on separate days in the morning, after an overnight fast, at the beginning and at the end of period 1, and at the end of period 2. The FMD of the brachial artery was performed by the same operator who was blinded to the treatment of participants. Ultrasound images were video recorded and analyzed by a trained reader who was blinded to the treatment of participants. In our laboratory, the intraobserver CV for FMD is 2.9%. A venous blood sample was taken at each visit, and serum samples were frozen at 280°C for subsequent analysis. Participants were requested to self-monitor their home fasting blood glucose concentrations by using a glucometer (Glucocard G meter; Menarini Diagnostics) each day of the 2 study periods; subjects measured blood glucose concentrations 6 times/d (before and 2 h after breakfast, lunch, and dinner, respectively) on the last day of each study period. The control subjects underwent the same measurements of subjects at increased CVR on 2 occasions at a 15-20-d interval. Throughout the study, participants were asked to maintain their usual dietary habits and physical exercise level. In particular, they were requested to follow a diet similar to that of the 3 d preceding basal measurements and also during the last 3 d of periods 1 and 2. To improve compliance, subjects were asked to compile a food diary the day before measurements.
Orange juice
The orange juice was obtained from 3 red orange varieties (ie, the following Citrus sinensis varieties: Tarocco, Sanguinello, and Moro) that were collected at maturity in Piana di Catania, Italy. Fruit were squeezed, and the obtained juice was filtered, pasteurized at 75°C, and stored at 220°C in aliquots of 500 mL (Agrumaria Corleone SpA). After defrosting, a centrifugation process at 6000 rpm for 15 min was performed, and the analytic composition of the juice was carried out. Acidity, pH, percentage of pulp,°Brix, Formol number, essential oil content, and total pectin content were obtained according to the Richtwerte und Schwankungsbreiten bestimmter kennzahlen method (17) . The total antocyanin content was measured by using the spectrophotometric method as reported by Rapisarda et al (18); cyanidin 3-glucoside (Extrasynthese) was used as a standard to construct a calibration curve. The radical scavenging activity of blood orange juice was measured by using a spectrophotometric method and the free stable radical 2,2-diphenyl-1-picryl-hydrazyl according to the method proposed by Brand-Williams et al (19) with minor modifications as described elsewhere (20) . The total content of the polyphenolic compound was measured by using the spectrophotometric method described by Asami et al (21) ; gallic acid (Fluka) was used as a standard to construct a calibration curve. The spectrophotometric method was also used to measure the ascorbic acid (vitamin C) and carotenoid contents. The vitamin C content was measured by using the enzymatic method, which is based on reducing the tetrazolyum salt 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazoliumbromide to formazano (L-ascorbic acid kit; Boehringer-Mannheim). The total carotenoid content was measured by using the method proposed by Lee (22) , which requires a preparatory extraction of carotenoids from the juice by using a solvent [hesane-acetoneethanol (50: 25: 25)]. A double-beam spectrophotometer (spectrophotometer DU Series 600; Beckman Instruments) was used for all absorbency measurements. Quantification of hesperidin and narirutin was performed by using a System Gold chromatograph (Beckman) with a model 168 photodiode array detector (23) . Quantification was performed by using external calibration with standards. Characteristics of the orange juice tested in this study are shown in Table 2 .
Measurements
Body composition and fat distribution
Fat mass (percentage of body weight) was estimated, as previously described (24) , by using bioelectrical impedance analysis (BIA-103, RJL; Akern). Body circumference was obtained at the umbilicus (waist circumference) and at the most prominent buttock level (hip circumference).
Carotid intima-media thickness
Images of the right and left extracranial carotid artery walls were obtained in several projections by using a high-resolution ultrasonographic 10-MHz linear array probe (Sonoline G50; Siemens); the end-diastolic intima-media thickness (IMT) of the far wall of both common carotid arteries was measured as described elsewhere (25) ; the highest value was considered for calculations. A single physician was responsible for performing the carotid and renal ultrasonographic examinations.
Assessment of endothelial function
Endothelium-dependent reactivity in the macrocirculation, which was measured by FMD of the brachial artery, was determined by using high-resolution vascular ultrasound (Sonoline G50; Siemens) with a 10-MHz linear array transducer. The transducer was held at the same position throughout the test by using a stereotactic clamp with micrometer adjustment (EDI Progetti e Sviluppo) to ensure image consistency. Reactive hyperemia was produced by inflating a sphygmomanometer cuff 2 cm below the antecubital fossa to occlude the artery for 5 min at ;220-250 mm Hg and then deflating the cuff. Twenty minutes after the FMD measurement, the endothelium-independent dilatation was assessed after the sublingual administration of 300 lg sublingual glyceryl-trinitrate (GTN). A video processing system computed the brachial artery diameter in real time by analyzing B-mode ultrasound images (FMD Studio; Institute of Physiology CNR). Briefly, the device captured the analog video signal from the ultrasound equipment. An edge-detection algorithm, which was based on the localization of gray level discontinuities, automatically located the 2 walls of the vessel. The diameter was obtained with subpixel precision and temporal resolution of 25 samples/s. The brachial artery diameters were displayed on a graphical interface over a time scale of 9 min. The baseline vessel size was considered the mean of the measures obtained during the first minute. Both the FMD and the GTN were calculated as the maximum percentage increase of the brachial artery diameter over baseline. These procedures were described in detail elsewhere (2, (26) (27) (28) .
Laboratory analysis
Basal lipid measurements and uric acid were ascertained by using standard clinical chemistry methods (ILTest CHOL, IL Test (29) . Plasma glucose concentrations were measured by using the glucose oxidase method (Instrumentation Laboratory). The plasma NO concentration was estimated by measuring nitrate and nitrite amounts as a marker of NO bioavailability by using the colorimetric method with a nitrate and nitrite colorimetric assay kit (Cayman Chemical). Plasma protein carbonyl (PC) groups were determined as biomarkers of oxidative stress by using a commercially available ELISA kit (BioCell Corporation Ltd). Serum IL-6, TNF-a (IL-6 human ELISA kit and TNF-a human ELISA kit; ENZO Life sciences) and high-sensitivity Creactive protein (hs-CRP human EIA; Caiman) were measured by using ELISA methods.
Statistical analysis
A power analysis for the paired t test showed that a total sample size of 15 subjects was required to detect a mean FMD difference of 2 (expected SD of difference of 2.5) with an a error of 0.05 and a power of 0.80. All data are presented as means 6 SDs. Basal comparisons between the CVR and control groups were tested for statistical significance using the unpaired Student's t test. Comparisons between measurements performed in the control group were tested by using the paired Student's t test. The ANOVA for repeated measures was performed to evaluate the effect of the 2 different beverages (orange juice and placebo) in the CVR group (3 periods as follows: baseline, orange juice week, and placebo week) on the variables of interest. Bonferroni's t test was performed for individual differences between 2 time points (paired) when appropriate. A 2-tailed P , 0.05 was considered significant. All analyses were performed with Systat software (Windows version 11.0; Systat).
RESULTS
Physical and clinical characteristics of the control and CVRs group are shown in Table 1 . No significant differences were observed in terms of intakes of energy, carbohydrates, lipids, and proteins on the basis of the information recorded in the diary complied by each study subject on the day preceding basal and period 1 and 2 measurements, respectively (data not shown). At the end of the 2 study periods, the body weight of the CVR group remained unchanged (89.6 6 17.9 compared with 89.3 6 18.0 kg, respectively; P = 0.160).
Blood glucose self-monitoring showed no significant differences during orange juice and placebo weeks. The average 6-d fasting glycemia concentrations were 95 6 13 mg/dL (orange juice) compared with 96 6 11 mg/dL (placebo) (P = 0.672). In the last day of each period, the average of 6 glucose determinations were not significantly different (95 6 13 compared with 94 6 13 mg/dL, respectively; P = 0.792); there was no statistical difference observed in preprandial (90 6 12 compared with 90 6 13 mg/dL, respectively; P = 0.972) and postprandial (99 6 16 compared with 97 6 17 mg/dL, respectively; P = 0.517) values.
The CVR group had a significantly lower FMD than that of the control group. The endothelial function increased significantly after 7 d of ROJ consumption and became comparable to the FMD of the control group (P = 0.658); after the placebo period, the FMD was unchanged and similar to the basal value. The GTN was similar between control and CVR groups and was not significantly influenced by the ROJ or placebo treatment. Endothelial function data are shown in Table 3 and Figure 1 .
Blood basal concentrations of hs-CRP, IL-6, and TNF-a were significantly higher in the CVR group than in the control group. These values decreased significantly after 1 wk of ROJ consumption. No difference was observed after the week of placebo consumption with respect to baseline (Table 3) .
PC concentrations were significantly higher in CVR subjects than in control subjects but were not affected by ROJ consumption (Table 3) .
DISCUSSION
During the study period, we did not record any underlying diseases or changes in the environment and lifestyle, including body weight and glycemia, that may have influenced the observed results. This study demonstrated that daily ROJ consumption rapidly improved and normalized in vivo endothelial function variables in nondiabetic subjects with increased CVR. To our knowledge, the effect of ROJ on endothelial function had not previously been investigated. Morand et al (30) have recently demonstrated that the daily consumption of 500 mL blond orange juice for 4 wk significantly improved endothelial function, which was assessed as the cutaneous acetylcholine microvascular reactivity by using Doppler laser flowmetry. This effect was observed in the postprandial phase but not under fasting conditions. The authors (30) attributed this favorable effect to the hesperidin shown in the orange juice they tested. Although hesperidin and narirutin were significantly represented in the ROJ investigated in our study, red oranges characteristically differ from blonde oranges in that ROJ also contains anthocyanins, which is another flavonoid subclass. It is unclear whether anthocyanins are poorly absorbed and have reduced bioavalability (31) or whether absorption is underestimated because of difficulties in the identification and measurement of all anthocyanin metabolites (32) (33) (34) . Recently, Dohadwala et al (35) tested the effects of cranberry juice, which is a beverage that contains a significant amount of anthocyanins, in subjects with coronary artery disease. Although they showed a reduction in the carotid femoral pulse wave velocity, which is a measure of arterial stiffness, the brachial artery FMD did not change. Therefore, the ROJ tested in our study seemed to induce a more sustained and stable improvement of endothelial function that that of similar fruit beverages. As shown in Table 2 , besides a high content of anthocyanins, the ROJ had a high content of vitamin C and carotenoids, which are all substances that might have contributed to the favorable endothelial effects observed in this study (36) .
We also showed evidence that ROJ had significant antiinflammatory effects that resulted in a reduction of hs-CRP concentrations. hs-CRP is a sensitive marker of inflammatory activation of the vessel wall and an indicator of CVR (37) . The reduction of hs-CRP concentrations seemed of particular interest because it has been reported that hs-CRP concentrations ,2 mg/L, which is a value similar to that we observed after ROJ consumption in the CVR group, are associated with an ;30% reduction in risk of cardiovascular events (38) . The concentrations of inflammatory cytokines measured in this study (ie, IL-6 and TNF-a) were also reduced after ROJ consumption. Subjects in the CVR group had significantly higher IMT, which suggested the presence of subclinical atherosclerosis besides endothelial dysfunction. Therefore, the observed reduction of hs-CRP, IL-6, and TNF-a concentrations may have dampened inflammatory signaling with potentially beneficial effects on atherosclerotic progression (39) . These results are in agreement with in vitro studies that showed an antiinflammatory action of red oranges (mediated by a reduced expression of intracellular adhesion molecule 1, monocyte chemoattractant protein-1, and IL-8) in normal human keratinocites stimulated with c-interferon and histamine (40) .
Hepatocyte's synthesis of CRP and other acute-phase proteins is stimulated by proinflammatory cytokines such as IL-6 and -1 and TNF-a, the expression of which is regulated by the activation of the proinflammatory transcription factor nuclear transcription factor jB (NF-jB) (41) that is mediated by ROS. Antioxidants inhibit ROS production, whereas increasing intracellular glucose concentrations induce ROS formation. ROJ contains specific antioxidant compounds, including anthocyanins, that are very active as ROS scavengers and may, thus, potentially interfere with transcription factors such as NF-jB. Other potential mechanisms include the modulation of antioxidant gene transcription via nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) signaling pathways (42) . However, studies that have investigated the role of anthocyanins in the activation of the Nrf2 pathway are sparse and essentially consist of in vitro experiments that focused on the mechanisms that prevent hepatotoxycity. Hwang et al (43) showed that anthocyanins induced protective and antiinflammatory effects on rat hepatocytes and inhibit NF-jB and induce the Nrf2 system; it cannot be excluded that both pathways are also involved in vivo, but this hypothesis remains to be investigated.
A reduction of oxidative stress biomarkers such as 8-isoprostaglandin F2a has been reported after consumption of blonde orange juice (44) or other polyphenol-rich beverages (45) . Free radicals and reactive oxygen and nitrogen species may react with proteins and lead to the conversion of amino acid residues into carbonyl groups. Therefore, PC concentrations are considered biomarkers of oxidative stress (46) . As expected, the CVR group exhibited higher serum PC concentrations than did the control group. ROJ consumption was followed by a nonsignificant trend toward a reduction of PC concentrations. It is possible that our study was underpowered for this variable, and a larger study may confirm this trend. It remains to be seen if higher ROJ doses or longer periods of ROJ intake might induce significant changes in PC concentrations.
To the best of our knowledge, this is the first study that compared the effects of ROJ compared with a placebo on FMD and inflammatory markers with a randomized, crossover, singleblind design. Nevertheless, this study has some intrinsic limitations that need to be acknowledged. Because of the different taste characteristics of the ROJ and placebo, it was not possible to design a fully double-blind study. However, we feel that the knowledge of the kind of beverage ingested by the study participants could not easily, per se, influence FMD or concentrations of inflammatory molecules.
We considered that 1 wk of ROJ daily consumption could elicit possible variations in the endpoints, and 7-10 d of ROJ suspension was a sufficient washout period, on the basis of the half- lives of the active substances shown in ROJ (33, 47, 48) . Longer treatment and washout periods were avoided to reduce the subject burden and the potential for bias factors (infections, spontaneous fluctuations in diet, and physical activity). When consumption of ROJ preceded that of the placebo, a carryover effect could not be formally excluded because of the short washout period and lack of sampling at the start of the second period. However, carryover effects 10 d after withdrawal would seem unlikely because of the ,4-h half-lives of polyphenols, anthocyanins, and flavonones (33) . Persisting effects of vitamin C and carotenoids might have been possible because of the longer half-lives (3 wk) (47, 48) , but study subjects did not have evident deficiencies (49, 50) , the extra intake of vitamin C is promptly excreted (47) , and studies have shown no acute effects of vitamin C and carotenoids (acute or chronic) on FMD (51, 52) . The shapes of individual FMD trajectories (Figure 1 ) argued against a significant carryover effect of ROJ.
We could not perform accurate evaluations of antioxidant activities, and we did not observe any significant change in serum NO concentrations according to ROJ consumption. However, systemic NO concentrations may be the result of a more complex balance. In fact, substances that have antioxidant and antiinflammatory effects induce endothelial nitric oxide synthase (eNOS), which increases local NO production; on the contrary, inflammation, as seen in the high-CVR patients in this study, has inhibitory effects on eNOS activity but stimulates the inducible nitric oxide synthase form that, in turn, increases circulating NO concentrations (53, 54) . Therefore, the unchanged NO blood concentrations observed in this study after ROJ consumption may have been the result of opposite effects on eNOS and inducible nitric oxide synthase and, thus, did not reflect changes at the endothelial level.
In conclusion, we observed favorable changes in FMD and inflammatory markers after the consumption of ROJ in subjects with increased CVR. Although these results may encourage the consumption of red oranges, intervention studies in the medium to long term are needed to test the effects of this food on metabolic and cardiovascular endpoints.
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